Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001076809-21-000039
Filing Date
2021-02-09
Accepted
2021-02-09 17:50:09
Documents
1
Period of Report
2021-01-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 3585
  Complete submission text file 0001076809-21-000039.txt   5537
Mailing Address 250 WEST 55TH STREET SUITE 30A NEW YORK NY 10019
Business Address 250 WEST 55TH STREET SUITE 30A NEW YORK NY 10019 212-808-7308
GLAZER CAPITAL, LLC (Reporting) CIK: 0001076809 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 001-39962 | Film No.: 21608164

Mailing Address 250 WEST 55TH ST SUITE 30A NEW YORK NY 10019
Business Address
GLAZER PAUL J (Reporting) CIK: 0001133985 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39962 | Film No.: 21608165

Mailing Address 4611 BEE CAVE RD. #106 AUSTIN TX 78746
Business Address 4611 BEE CAVE RD. #106 AUSTIN TX 78746 512.329.6977
EQ Health Acquisition Corp. (Issuer) CIK: 0001826729 (see all company filings)

EIN.: 852877347 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6770 Blank Checks